OpenURL Connection Search

Select item for more details and to access through your institution.

Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer.
Published in:
2016
By:
- Said, Rabih;
- Kakadiaris, Eugenia;
- Piha-Paul, Sarina;
- Fu, Siqing;
- Falchook, Gerald;
- Janku, Filip;
- Wheler, Jennifer;
- Zinner, Ralph;
- Hong, David;
- Kurzrock, Razelle;
- Tsimberidou, Apostolia;
- Wheler, Jennifer J;
- Hong, David S;
- Tsimberidou, Apostolia M
Publication type:
journal article
The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes.
Published in:
2008
By:
- Tsimberidou, Apóstolia Maria;
- Estey, Elihu;
- Sijin Wen;
- Pierce, Sherry;
- Kantarjian, Hagop;
- Albitar, Maher;
- Kurzrock, Razellé;
- Tsimberidou, Apostolia Maria;
- Wen, Sijin;
- Kurzrock, Razelle
Publication type:
journal article
The Significance of Anemia in Elderly Patients with Cancer.
Published in:
Oncology (08909091), 2007, v. 21, n. 1, p. 100
By:
- Tsimberidou, Apostolia-Maria;
- Estey, Elihu H.
Publication type:
Article
Clinical Outcomes of Patients With Breast Cancer in a Phase I Clinic: The M. D. Anderson Cancer Center Experience.
Published in:
Clinical Breast Cancer, 2010, v. 10, n. 1, p. 46, doi. 10.3816/CBC.2010.n.006
By:
- Wheler, Jennifer;
- Tsimberidou, Apostolia M.;
- Moulder, Stacy;
- Cristofanilli, Massimo;
- Hong, David;
- Naing, Aung;
- Pathak, Raminder;
- Liu, Suyu;
- Feng, Lei;
- Kurzrock, Razelle
Publication type:
Article
Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12669-5
By:
- Yao, Shuyang;
- Meric-Bernstam, Funda;
- Hong, David;
- Janku, Filip;
- Naing, Aung;
- Piha-Paul, Sarina Anne;
- Tsimberidou, Apostolia Maria;
- Karp, Daniel;
- Subbiah, Vivek;
- Yap, Timothy Anthony;
- Ahnert, Jordi Rodon;
- Pant, Shubham;
- Dumbrava, Ecaterina E Ileana;
- Wathoo, Chetna;
- Campbell, Erick;
- Yu, Lihou;
- Yamamura, Yuko;
- Fu, Siqing
Publication type:
Article
Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine.
Published in:
Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. 1, doi. 10.1186/s13045-019-0835-1
By:
- Tsimberidou, Apostolia-Maria;
- Hong, David S.;
- Wheler, Jennifer J.;
- Falchook, Gerald S.;
- Janku, Filip;
- Naing, Aung;
- Fu, Siqing;
- Piha-Paul, Sarina;
- Cartwright, Carrie;
- Broaddus, Russell R.;
- Nogueras Gonzalez, Graciela M.;
- Hwu, Patrick;
- Kurzrock, Razelle
Publication type:
Article
Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-16588-3
By:
- Mendoza, Tito R.;
- Hong, David S.;
- Peterson, Christine B.;
- Stephen, Bettzy;
- Dumbrava, Ecaterina;
- Pant, Shubbam;
- Tsimberidou, Apostolia Maria;
- Yap, Timothy Anthony;
- Sheshadri, Ajay;
- Altan, Mehmet;
- George, Goldy;
- Castillo, Lilibeth;
- Rodriguez, Enedelia;
- Gong, Jing;
- Subbiah, Vivek;
- Janku, Filip;
- Fu, Siqing;
- Piha-Paul, Sarina A.;
- Ahnert, Jordi Rodon;
- Karp, Daniel D.
Publication type:
Article
Managing Cardiac Risk Factors in Oncology Clinical Trials.
Published in:
Texas Heart Institute Journal, 2011, v. 38, n. 3, p. 266
By:
- Tsimberidou, Apostolia-Maria;
- Minotti, Giorgio;
- Cardinale, Daniela
Publication type:
Article
Clinical trial design in the era of precision medicine.
Published in:
Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01102-1
By:
- Fountzilas, Elena;
- Tsimberidou, Apostolia M.;
- Vo, Henry Hiep;
- Kurzrock, Razelle
Publication type:
Article
Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies.
Published in:
2011
By:
- Hong, David S;
- Cabanillas, Maria E;
- Wheler, Jennifer;
- Naing, Aung;
- Tsimberidou, Apostolia M;
- Ye, Lei;
- Busaidy, Naifa L;
- Waguespack, Steven G;
- Hernandez, Mike;
- El Naggar, Adel K;
- El Naggar, Alder K;
- Bidyasar, Savita;
- Wright, John;
- Sherman, Steven I;
- Kurzrock, Razelle
Publication type:
journal article
Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single‑center, multi‑arm phase Ib study.
Published in:
2022
By:
- Thein, Kyaw Z.;
- Karp, Daniel D.;
- Tsimberidou, Apostolia;
- Gong, Jing;
- Sulovic, Selma;
- Shah, Jatin;
- Milton, Denái R.;
- Hong, David S.;
- Janku, Filip;
- McQuinn, Lacey;
- Stephen, Bettzy A.;
- Colen, Rivka;
- Carter, Brett W.;
- Yap, Timothy A.;
- Piha‑Paul, Sarina A.;
- Fu, Siqing;
- Meric‑Bernstam, Funda;
- Naing, Aung
Publication type:
Correction Notice
Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
Published in:
2022
By:
- Thein, Kyaw Zin;
- Piha-Paul, Sarina A.;
- Tsimberidou, Apostolia;
- Karp, Daniel D.;
- Janku, Filip;
- Zarifa, Abdulrazzak;
- Shah, Jatin;
- Milton, Denái R.;
- Bean, Stacie;
- McQuinn, Lacey;
- Gong, Jing;
- Colen, Rivka;
- Carter, Brett W.;
- Subbiah, Vivek;
- Ogbonna, Deby C.;
- Pant, Shubham;
- Meric-Bernstam, Funda;
- Naing, Aung
Publication type:
Correction Notice
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.
Published in:
Investigational New Drugs, 2022, v. 40, n. 2, p. 290, doi. 10.1007/s10637-021-01188-1
By:
- Thein, Kyaw Z.;
- Karp, Daniel D.;
- Tsimberidou, Apostolia;
- Gong, Jing;
- Sulovic, Selma;
- Shah, Jatin;
- Milton, Denái R.;
- Hong, David S.;
- Janku, Filip;
- McQuinn, Lacey;
- Stephen, Bettzy A.;
- Colen, Rivka;
- Carter, Brett W.;
- Yap, Timothy A.;
- Piha-Paul, Sarina A.;
- Fu, Siqing;
- Meric-Bernstam, Funda;
- Naing, Aung
Publication type:
Article
Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study.
Published in:
Investigational New Drugs, 2022, v. 40, n. 1, p. 124, doi. 10.1007/s10637-021-01184-5
By:
- Dev, Rony;
- Zhong, Linda L.;
- Zarifa, Abdulrazzak;
- Albittar, Aya A.;
- Rubin, Laura;
- Liu, Suyu;
- Yap, Timothy A.;
- Dalal, Shalini;
- Hui, David;
- Karp, Daniel D.;
- Tsimberidou, Apostolia M.;
- Piha-Paul, Sarina A.;
- Ahnert, Jordi Rodon;
- Fu, Siqing;
- Meric-Bernstam, Funda;
- Naing, Aung
Publication type:
Article
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi‐arm phase Ib study.
Published in:
Investigational New Drugs, 2021, v. 39, n. 5, p. 1357, doi. 10.1007/s10637-021-01119-0
By:
- Thein, Kyaw Zin;
- Piha-Paul, Sarina A.;
- Tsimberidou, Apostolia;
- Karp, Daniel D.;
- Janku, Filip;
- Zarifa, Abdulrazzak;
- Shah, Jatin;
- Milton, Denái R.;
- Bean, Stacie;
- McQuinn, Lacey;
- Gong, Jing;
- Colen, Rivka;
- Carter, Brett W.;
- Subbiah, Vivek;
- Ogbonna, Deby C.;
- Pant, Shubham;
- Meric-Bernstam, Funda;
- Naing, Aung
Publication type:
Article
Factors affecting symptom presentation in an early-phase clinical trials clinic patient population.
Published in:
Investigational New Drugs, 2020, v. 38, n. 4, p. 1166, doi. 10.1007/s10637-019-00879-0
By:
- George, Goldy C.;
- Mendoza, Tito R.;
- Iwuanyanwu, Eucharia C.;
- Manandhar, Meryna;
- Afshar, Solmaz F.;
- Piha-Paul, Sarina A.;
- Tsimberidou, Apostolia;
- Naing, Aung;
- Cleeland, Charles S.;
- Hong, David S.
Publication type:
Article
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience.
Published in:
Investigational New Drugs, 2018, v. 36, n. 4, p. 638, doi. 10.1007/s10637-017-0534-0
By:
- Fujii, Takeo;
- Colen, Rivka R.;
- Bilen, Mehmet Asim;
- Hess, Kenneth R.;
- Hajjar, Joud;
- Suarez-Almazor, Maria E.;
- Alshawa, Anas;
- Hong, David S.;
- Tsimberidou, Apostolia;
- Janku, Filip;
- Gong, Jing;
- Stephen, Bettzy;
- Subbiah, Vivek;
- Piha-Paul, Sarina A.;
- Fu, Siqing;
- Sharma, Padmanee;
- Mendoza, Tito;
- Patel, Anisha;
- Thirumurthi, Selvi;
- Sheshadri, Ajay
Publication type:
Article
Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer.
Published in:
Investigational New Drugs, 2018, v. 36, n. 3, p. 416, doi. 10.1007/s10637-017-0513-5
By:
- Kato, Shumei;
- Jardim, Denis L.;
- Johnson, Faye M.;
- Subbiah, Vivek;
- Piha-Paul, Sarina;
- Tsimberidou, Apostolia M.;
- Falchook, Gerald S.;
- Karp, Daniel;
- Zinner, Ralph;
- Wheler, Jennifer;
- Janku, Filip;
- Fu, Siqing;
- Lim, JoAnn;
- Bean, Stacie;
- Nguyen, Ly;
- Urban, Susan;
- Browne, Elsa;
- Meric-Bernstam, Funda;
- Hong, David S.
Publication type:
Article
Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver.
Published in:
Investigational New Drugs, 2015, v. 33, n. 4, p. 911, doi. 10.1007/s10637-015-0251-5
By:
- Said, Rabih;
- Kurzrock, Razelle;
- Naing, Aung;
- Hong, David;
- Fu, Siqing;
- Piha-Paul, Sarina;
- Wheler, Jennifer;
- Janku, Filip;
- Kee, Bryan;
- Bidyasar, Savita;
- Lim, Joann;
- Wallace, Michael;
- Tsimberidou, Apostolia
Publication type:
Article
Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer.
Published in:
Investigational New Drugs, 2015, v. 33, n. 3, p. 621, doi. 10.1007/s10637-015-0226-6
By:
- Hong, David;
- Janku, Filip;
- Naing, Aung;
- Falchook, Gerald;
- Piha-Paul, Sarina;
- Wheler, Jennifer;
- Fu, Siqing;
- Tsimberidou, Apostolia;
- Stecher, Michael;
- Mohanty, Prasant;
- Simard, John;
- Kurzrock, Razelle
Publication type:
Article
Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.
Published in:
Investigational New Drugs, 2015, v. 33, n. 3, p. 700, doi. 10.1007/s10637-015-0238-2
By:
- Rodrigues, Heloisa;
- Ke, Danxia;
- Lim, JoAnn;
- Stephen, Bettzy;
- Bellido, Jorge;
- Janku, Filip;
- Zinner, Ralph;
- Tsimberidou, Apostolia;
- Hong, David;
- Piha-Paul, Sarina;
- Fu, Siqing;
- Naing, Aung;
- Subbiah, Vivek;
- Karp, Daniel;
- Falchook, Gerald;
- Kurzrock, Razelle;
- Wheler, Jennifer
Publication type:
Article
Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors.
Published in:
Investigational New Drugs, 2015, v. 33, n. 1, p. 215, doi. 10.1007/s10637-014-0176-4
By:
- Falchook, Gerald;
- Wheler, Jennifer;
- Naing, Aung;
- Piha-Paul, Sarina;
- Fu, Siqing;
- Tsimberidou, Apostolia;
- Hong, David;
- Janku, Filip;
- Zinner, Ralph;
- Jiang, Yunfang;
- Huang, Mei;
- Lin, Quan;
- Parkhurst, Kristin;
- Kurzrock, Razelle
Publication type:
Article
A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer.
Published in:
Investigational New Drugs, 2015, v. 33, n. 1, p. 177, doi. 10.1007/s10637-014-0173-7
By:
- Falchook, Gerald;
- Moulder, Stacy;
- Naing, Aung;
- Wheler, Jennifer;
- Hong, David;
- Piha-Paul, Sarina;
- Tsimberidou, Apostolia;
- Fu, Siqing;
- Zinner, Ralph;
- Janku, Filip;
- Jiang, Yunfang;
- Huang, Mei;
- Parkhurst, Kristin;
- Kurzrock, Razelle
Publication type:
Article
Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non-small-cell Lung Cancer.
Published in:
2020
By:
- Tsimberidou, Apostolia M.;
- Elkin, Sheryl;
- Dumanois, Robert;
- Pritchard, Daryl
Publication type:
journal article
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies.
Published in:
Scientific Reports, 2016, p. 35448, doi. 10.1038/srep35448
By:
- Subbiah, Vivek;
- Hess, Kenneth R.;
- Khawaja, Muhammad Rizwan;
- Wagner, Michael J.;
- Tang, Chad;
- Naing, Aung;
- Fu, Siqing;
- Janku, Filip;
- Piha-Paul, Sarina;
- Tsimberidou, Apostolia M.;
- Herzog, Cynthia E.;
- Ludwig, Joseph A.;
- Patel, Shreyaskumar;
- Ravi, Vinod;
- Benjamin, Robert S.;
- Meric-Bernstam, Funda;
- Hong, David S.
Publication type:
Article
Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial.
Published in:
Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40164-020-00159-1
By:
- Subbiah, Vivek;
- Dumbrava, Ecaterina Ileana;
- Jiang, Yunfang;
- Thein, Kyaw Z.;
- Naing, Aung;
- Hong, David S.;
- Fu, Siqing;
- Piha-Paul, Sarina A.;
- Tsimberidou, Apostolia M.;
- Janku, Filip;
- Meric-Bernstam, Funda;
- Kurzrock, Razelle;
- Falchook, Gerald
Publication type:
Article
Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211001538
By:
- Naqvi, Mohammad Faraz;
- Vo, Henry Hiep;
- Vining, David;
- Tsimberidou, Apostolia-Maria
Publication type:
Article
Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211001538
By:
- Naqvi, Mohammad Faraz;
- Vo, Henry Hiep;
- Vining, David;
- Tsimberidou, Apostolia-Maria
Publication type:
Article
<i>FBXW7</i> Mutations in Patients with Advanced Cancers: Clinical and Molecular Characteristics and Outcomes with mTOR Inhibitors.
Published in:
PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0089388
By:
- Jardim, Denis L.;
- Wheler, Jennifer J.;
- Hess, Kenneth;
- Tsimberidou, Apostolia M.;
- Zinner, Ralph;
- Janku, Filip;
- Subbiah, Vivek;
- Naing, Aung;
- Piha-Paul, Sarina A.;
- Westin, Shannon N.;
- Roy-Chowdhuri, Sinchita;
- Meric-Bernstam, Funda;
- Hong, David S.
Publication type:
Article
BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes.
Published in:
PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0025806
By:
- El-Osta, Hazem;
- Falchook, Gerald;
- Tsimberidou, Apostolia;
- Hong, David;
- Naing, Aung;
- Kim, Kevin;
- Sijin Wen;
- Janku, Filip;
- Kurzrock, Razelle
Publication type:
Article
PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers.
Published in:
PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0022769
By:
- Janku, Filip;
- Lee, J. Jack;
- Tsimberidou, Apostolia M.;
- Hong, David S.;
- Naing, Aung;
- Falchook, Gerald S.;
- Siqing Fu;
- Luthra, Rajyalakshmi;
- Garrido-Laguna, Ignacio;
- Kurzrock, Razelle
Publication type:
Article
Phase I clinical trials in 56 patients with thyroid cancer: the M. D. Anderson Cancer Center experience.
Published in:
2009
By:
- Tsimberidou, Apostolia Maria;
- Vaklavas, Christos;
- Wen, Sijin;
- Hong, David;
- Wheler, Jennifer;
- Ng, Chaan;
- Naing, Aung;
- Tse, Susan;
- Busaidy, Naifa;
- Markman, Maurie;
- Sherman, Steven I;
- Kurzrock, Razelle
Publication type:
journal article
A nonparametric Bayesian basket trial design.
Published in:
Biometrical Journal, 2019, v. 61, n. 5, p. 1160, doi. 10.1002/bimj.201700162
By:
- Xu, Yanxun;
- Müller, Peter;
- Tsimberidou, Apostolia M.;
- Berry, Donald
Publication type:
Article
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.
Published in:
British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1836, doi. 10.1111/bcp.14289
By:
- Mahalingam, Devalingam;
- Patel, Manish R.;
- Sachdev, Jasgit C.;
- Hart, Lowell L.;
- Halama, Niels;
- Ramanathan, Ramesh K.;
- Sarantopoulos, John;
- Völkel, Dirk;
- Youssef, Ashraf;
- Jong, Floris A.;
- Tsimberidou, Apostolia Maria
Publication type:
Article
Physiologically‐based pharmacokinetic modelling to predict oprozomib CYP3A drug–drug interaction potential in patients with advanced malignancies.
Published in:
British Journal of Clinical Pharmacology, 2019, v. 85, n. 3, p. 530, doi. 10.1111/bcp.13817
By:
- Ou, Ying;
- Xu, Yang;
- Gore, Lia;
- Harvey, R. Donald;
- Mita, Alain;
- Papadopoulos, Kyriakos P.;
- Wang, Zhengping;
- Cutler, Richard E.;
- Pinchasik, Dawn E.;
- Tsimberidou, Apostolia M.
Publication type:
Article
Precision Oncology: Evolving Clinical Trials across Tumor Types.
Published in:
Cancers, 2023, v. 15, n. 7, p. 1967, doi. 10.3390/cancers15071967
By:
- Song, I-Wen;
- Vo, Henry Hiep;
- Chen, Ying-Shiuan;
- Baysal, Mehmet A.;
- Kahle, Michael;
- Johnson, Amber;
- Tsimberidou, Apostolia M.
Publication type:
Article
Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center.
Published in:
Cancers, 2022, v. 14, n. 5, p. 1330, doi. 10.3390/cancers14051330
By:
- Vo, Henry Hiep;
- Cartwright, Carrie;
- Song, I-Wen;
- Karp, Daniel D.;
- Nogueras Gonzalez, Graciela M.;
- Xie, Yuran;
- Karol, Michael;
- Hitron, Matthew;
- Vining, David;
- Tsimberidou, Apostolia-Maria
Publication type:
Article
Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas.
Published in:
Cancers, 2020, v. 12, n. 8, p. 2307, doi. 10.3390/cancers12082307
By:
- Jimenez, Camilo;
- Subbiah, Vivek;
- Stephen, Bettzy;
- Ma, Junsheng;
- Milton, Denai;
- Xu, Mingxuan;
- Zarifa, Abdualrazzak;
- Akhmedzhanov, Fechukwu Omolara;
- Tsimberidou, Apostolia;
- Habra, Mouhammed Amir;
- Rodon Anhert, Jordi;
- Fu, Siqing;
- Naing, Aung
Publication type:
Article
Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies.
Published in:
Investigational New Drugs, 2014, v. 32, n. 3, p. 465, doi. 10.1007/s10637-013-0051-8
By:
- Fu, Siqing;
- Hou, Ming-Mo;
- Wheler, Jennifer;
- Hong, David;
- Naing, Aung;
- Tsimberidou, Apostolia;
- Janku, Filip;
- Zinner, Ralph;
- Piha-Paul, Sarina;
- Falchook, Gerald;
- Kuo, Macus;
- Kurzrock, Razelle
Publication type:
Article
Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer.
Published in:
Investigational New Drugs, 2014, v. 32, n. 2, p. 279, doi. 10.1007/s10637-013-9966-3
By:
- Ganesan, Prasanth;
- Piha-Paul, Sarina;
- Naing, Aung;
- Falchook, Gerald;
- Wheler, Jennifer;
- Fu, Siqing;
- Hong, David;
- Kurzrock, Razelle;
- Janku, Filip;
- Laday, Shell;
- Bedikian, Agop;
- Kies, Merrill;
- Wolff, Robert;
- Tsimberidou, Apostolia
Publication type:
Article
Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer.
Published in:
Investigational New Drugs, 2013, v. 31, n. 6, p. 1505, doi. 10.1007/s10637-013-0013-1
By:
- Ganesan, Prasanth;
- Piha-Paul, Sarina;
- Naing, Aung;
- Falchook, Gerald;
- Wheler, Jennifer;
- Janku, Filip;
- Zinner, Ralph;
- Laday, Shell;
- Kies, Merrill;
- Tsimberidou, Apostolia
Publication type:
Article
Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors.
Published in:
Cancer Medicine, 2022, v. 11, n. 2, p. 340, doi. 10.1002/cam4.4446
By:
- Yao, Shuyang;
- Janku, Filip;
- Koenig, Kimberly;
- Tsimberidou, Apostolia Maria;
- Piha‐Paul, Sarina Anne;
- Shi, Nai;
- Stewart, John;
- Johnston, Amanda;
- Bomalaski, John;
- Meric‐Bernstam, Funda;
- Fu, Siqing
Publication type:
Article
Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience.
Published in:
Cancer Medicine, 2016, v. 5, n. 12, p. 3437, doi. 10.1002/cam4.956
By:
- Wang, Zhijie;
- Shi, Naiyi;
- Naing, Aung;
- Janku, Filip;
- Subbiah, Vivek;
- Araujo, Dejka M.;
- Patel, Shreyaskumar R.;
- Ludwig, Joseph A.;
- Ramondetta, Lois M.;
- Levenback, Charles F.;
- Ramirez, Pedro T.;
- Piha‐Paul, Sarina A.;
- Hong, David;
- Karp, Daniel D.;
- Tsimberidou, Apostolia M.;
- Meric‐Bernstam, Funda;
- Fu, Siqing
Publication type:
Article
A phase I study of fludarabine, cytarabine, and oxaliplatin therapy in patients with relapsed or refractory acute myeloid leukemia.
Published in:
2014
By:
- Tsimberidou, Apostolia Maria;
- Keating, Michael J.;
- Jabbour, Elias J.;
- Ravandi-Kashani, Farhad;
- O'Brien, Susan;
- Estey, Elihu;
- Bekele, Neby;
- Plunkett, Jr., William K.;
- Kantarjian, Hagop;
- Borthakur, Gautam;
- Plunkett, William K Jr
Publication type:
journal article
Phase I-II Clinical Trial of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Therapy in Aggressive Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 5, p. 568, doi. 10.1016/j.clml.2013.03.012
By:
- Tsimberidou, Apostolia M.;
- Wierda, William G.;
- Wen, Sijin;
- Plunkett, William;
- O'Brien, Susan;
- Kipps, Thomas J.;
- Jones, Jeffrey A.;
- Badoux, Xavier;
- Kantarjian, Hagop;
- Keating, Michael J.
Publication type:
Article
Hodgkin transformation of chronic lymphocytic leukemia: The M. D. Anderson Cancer Center experience.
Published in:
Cancer (0008543X), 2006, v. 107, n. 6, p. 1294
By:
- Apostolia‐Maria Tsimberidou;
- Susan O'Brien;
- Hagop M. Kantarjian;
- Charles Koller;
- Fredrick B. Hagemeister;
- Luis Fayad;
- Susan Lerner;
- Carlos E. Bueso‐Ramos;
- Michael J. Keating
Publication type:
Article
Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
Published in:
2006
By:
- Tsimberidou, Apostolia M;
- Catovsky, Daniel;
- Schlette, Ellen;
- O'Brien, Susan;
- Wierda, William G;
- Kantarjian, Hagop;
- Garcia-Manero, Guillermo;
- Wen, Sijin;
- Do, Kim-Anh;
- Lerner, Susan;
- Keating, Michael J
Publication type:
journal article
Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
Published in:
Cancer (0008543X), 2006, v. 107, n. 1, p. 125
By:
- Apostolia M. Tsimberidou;
- Daniel Catovsky;
- Ellen Schlette;
- Susan O'Brien;
- William G. Wierda;
- Hagop Kantarjian;
- Guillermo Garcia‐Manero;
- Sijin Wen;
- Kim‐Anh Do;
- Susan Lerner;
- Michael J. Keating
Publication type:
Article
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.
Published in:
Cancer (0008543X), 2005, v. 104, n. 2, p. 345, doi. 10.1002/cncr.21151
By:
- Apostolia‐Maria Tsimberidou;
- Anas Younes;
- Jorge Romaguera;
- Fredrick B. Hagemeister;
- Maria A. Rodriguez;
- Lei Feng;
- Ana Ayala;
- Terry L. Smith;
- Fernando Cabanillas;
- Peter McLaughlin
Publication type:
Article
Richter syndrome: Biology, incidence, and therapeutic strategies.
Published in:
Cancer (0008543X), 2005, v. 103, n. 2, p. 216
By:
- Apostolia-Maria Tsimberidou;
- Michael J. Keating
Publication type:
Article

Found: 137